Division of Neurosurgery, Rebound Orthopedics and Neurosurgery, Portland, Oregon, USA.
Division of Physiatry, Rebound Orthopedics and Neurosurgery, Portland, Oregon, USA.
Pain Pract. 2024 Jan;24(1):91-100. doi: 10.1111/papr.13289. Epub 2023 Aug 25.
Neurologic deficit is known as a rare complication of thoracic spinal cord stimulator (SCS) paddle lead implantation, but many believe its incidence after SCS paddle lead placement is under-reported. It is possible that imaging characteristics may be used to help predict safe paddle lead placement.
This imaging study was undertaken to determine the minimum canal diameter required for safe paddle lead placement.
Patients who underwent thoracic laminotomy for new SCS paddle lead placement from January 2018 to March 2023 were identified retrospectively. Preoperative thoracic canal diameter was measured in the sagittal plane perpendicular to the disc space from T5/6 to T11/12. These thoracic levels were chosen because they span the most common levels targeted for SCS placement. Patients with and without new neurologic deficits were compared using a Mann-Whitney U-test.
Of 185 patients initially identified, 180 had thoracic imaging available for review. One (0.5%) and 2 (1.1%) of 185 patients complained of permanent and transient neurologic deficit after thoracic SCS placement, respectively. Patients with neurologic deficits had average canal diameters of <11 mm. The average canal diameter of patients with and without neurologic deficits was 10.2 mm (range 6.1-12.9 mm) and 13.0 mm (range 5.9-20.2), respectively (p < 0.0001).
Postoperative neurologic deficit is an uncommon complication after thoracic laminotomy for SCS paddle lead placement. The authors recommend ensuring a starting thoracic canal diameter of at least 12 mm to accommodate a SCS paddle lead measuring 2 mm thick to ensure a final diameter of >10 mm. If canal diameter is <12 mm, aggressive undercutting of the lamina, a second laminotomy, or placement of smaller SCS wire leads should be considered.
神经功能缺损是胸椎脊髓刺激器(SCS)板状电极植入的罕见并发症,但许多人认为 SCS 板状电极植入后其发生率被低估了。影像学特征可能有助于预测安全的板状电极放置。
本影像学研究旨在确定安全放置板状电极所需的最小椎管直径。
回顾性分析 2018 年 1 月至 2023 年 3 月期间因新的 SCS 板状电极植入而接受胸椎椎板切开术的患者。在矢状面垂直于 T5/6 至 T11/12 椎间盘空间测量术前胸椎管直径。选择这些胸椎水平是因为它们跨越了 SCS 放置最常见的目标水平。使用 Mann-Whitney U 检验比较有无新神经功能缺损的患者。
最初确定的 185 例患者中,180 例有胸椎影像学可供复查。185 例患者中,1 例(0.5%)和 2 例(1.1%)分别在接受胸椎 SCS 放置后出现永久性和短暂性神经功能缺损。有神经功能缺损的患者平均椎管直径<11mm。有神经功能缺损和无神经功能缺损患者的平均椎管直径分别为 10.2mm(范围 6.1-12.9mm)和 13.0mm(范围 5.9-20.2mm)(p<0.0001)。
胸椎椎板切开术治疗 SCS 板状电极植入术后神经功能缺损是一种罕见的并发症。作者建议,为了确保最终直径>10mm,应确保起始胸椎管直径至少为 12mm,以容纳 2mm 厚的 SCS 板状电极。如果椎管直径<12mm,则应考虑积极切除椎板、再次行椎板切开术或放置较小的 SCS 导丝电极。